Medical device and MedTech insights, news, tips and more

Nexstim Plc Appoints John Liedtky as VP of Commercialization, General Manager US

April 1, 2016



Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, today announces the appointment of John Liedtky as VP of Commercialization, General Manager US, effective from 1 April 2016. Mr. Liedtky will also join Nexstim Management Team and will be responsible of Pre-Surgical Mapping business and commercial development of therapeutic indications. At the same time, Nexstim announces the planned retirement of John Hardin, Vice President, Pre-surgical Mapping from Nexstim’s Management Team on 6 May 2016.

John Liedtky is a global healthcare executive with extensive experience in the medical device and equipment space, having previously held Global Marketing Vice Presidency Roles at DJO Global, COVIDIEN and BREG Inc.  John Liedtky is an expert in leading cross-functional teams through the complete product life-cycle, from upstream development to strategic downstream marketing and sales management tactics, and has experience with a breadth of technologies and business models in both the US and Internationally.

*Nexstim’s CEO, Janne* *Huhtala, said:* “We welcome John Liedtky to the team as we continue to grow in the important US market, both in PSM and therapeutic indications.  We thank John Hardin for the significant contribution that he has made to Nexstim and are grateful for all that he has done for pre-surgical mapping, our NBS system and the Company.  We wholeheartedly wish him well for the future. ”

Janne Huhtala, CEO

Read More – Source: Nexstim Plc Appoints John Liedtky as VP of Commercialization, General Manager US and announces the retirement of John Hardin – One News Page

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.